Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
4.935
-0.190 (-3.72%)
Mar 3, 2026, 4:00 PM EST - Market closed
Molecular Partners AG Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Molecular Partners AG stock have an average target of 8.38, with a low estimate of 3.75 and a high estimate of 13. The average target predicts an increase of 69.82% from the current stock price of 4.93.
Analyst Consensus: Buy
* Price targets were last updated on Jan 27, 2026.
Analyst Ratings
The average analyst rating for Molecular Partners AG stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +163.45% | Jan 27, 2026 |
| JP Morgan | JP Morgan | Hold Maintains $4 → $3.75 | Hold | Maintains | $4 → $3.75 | -24.01% | Dec 8, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $4.5 → $4 | Hold | Maintains | $4.5 → $4 | -18.94% | Sep 3, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $6.6 → $4.5 | Hold | Maintains | $6.6 → $4.5 | -8.81% | Dec 5, 2023 |
| SVB Leerink | SVB Leerink | Buy → Hold Downgrades $30 → $8 | Buy → Hold | Downgrades | $30 → $8 | +62.12% | Aug 29, 2022 |
Financial Forecast
Revenue This Year
1.79M
from 4.97M
Decreased by -64.08%
Revenue Next Year
6.89M
from 1.79M
Increased by 285.71%
EPS This Year
-1.56
from -1.59
EPS Next Year
-1.52
from -1.56
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 5.3M | 23.1M | ||||
| Avg | 1.8M | 6.9M | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 5.6% | 1,194.1% | ||||
| Avg | -64.1% | 285.7% | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.45 | -0.62 | ||||
| Avg | -1.56 | -1.52 | ||||
| Low | -1.57 | -1.93 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.